@article{4b1968f9782e497a9b159de44089c6fd,
title = "Final Results of Phase I/II Trial of the Oral mTOR Inhibitor Everolimus (RAD001) in Combination with Bortezomib and Rituximab (RVR) in Relapsed or Refractory Waldenstrom Macroglobulinemia",
author = "Ghobrial, \{Irene M.\} and Redd, \{Robert Allyn\} and Jeffrey Matous and Philippe Armand and Boswell, \{Erica N\} and Stacey Chuma and Kimberly Noonan and MacNabb, \{Megan H.\} and Ranjit Banwait and Courtney Hanlon and Houry Leblebjian and Diane Warren and Castillo, \{Jorge J.\} and Laubach, \{Jacob P.\} and Paba-Prada, \{Claudia E.\} and Anderson, \{Kenneth C.\} and Richardson, \{Paul G.\} and Weller, \{Edie A.\} and Treon, \{Steven P\}",
note = "624. Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models: Poster II | Irene M. Ghobrial, Robert Allyn Redd, Jeffrey Matous, Philippe Armand, Erica N Boswell, Stacey Chuma, Kimberly Noonan, Megan H. MacNabb, Ranjit Banwait, Courtney Hanlon, Houry Leblebjian, Diane Warren, Jorge J. Castillo, Jacob P. Laubach, Claudia E. Paba-Prada, Kenneth C.",
year = "2014",
month = dec,
day = "6",
doi = "10.1182/BLOOD.V124.21.3081.3081",
language = "American English",
volume = "124",
journal = "Blood",
publisher = "American Society of Hematology",
number = "21",
}